U.S. flag

An official website of the United States government

NM_001904.4(CTNNB1):c.100G>A (p.Gly34Arg) AND Pilomatrixoma

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jul 14, 2015
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000444074.1

Allele description [Variation Report for NM_001904.4(CTNNB1):c.100G>A (p.Gly34Arg)]

NM_001904.4(CTNNB1):c.100G>A (p.Gly34Arg)

Genes:
LOC126806658:BRD4-independent group 4 enhancer GRCh37_chr3:41265899-41267098 [Gene]
CTNNB1:catenin beta 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p22.1
Genomic location:
Preferred name:
NM_001904.4(CTNNB1):c.100G>A (p.Gly34Arg)
HGVS:
  • NC_000003.12:g.41224612G>A
  • NG_013302.2:g.30162G>A
  • NM_001098209.2:c.100G>A
  • NM_001098210.2:c.100G>A
  • NM_001330729.2:c.79G>A
  • NM_001904.4:c.100G>AMANE SELECT
  • NP_001091679.1:p.Gly34Arg
  • NP_001091680.1:p.Gly34Arg
  • NP_001317658.1:p.Gly27Arg
  • NP_001895.1:p.Gly34Arg
  • LRG_1108t1:c.100G>A
  • LRG_1108:g.30162G>A
  • LRG_1108p1:p.Gly34Arg
  • NC_000003.11:g.41266103G>A
Protein change:
G27R
Links:
dbSNP: rs121913399
NCBI 1000 Genomes Browser:
rs121913399
Molecular consequence:
  • NM_001098209.2:c.100G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001098210.2:c.100G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001330729.2:c.79G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001904.4:c.100G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Pilomatrixoma (PTR)
Synonyms:
EPITHELIOMA CALCIFICANS OF MALHERBE; Pilomatricoma; Calcifying epithelioma of Malherbe; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007564; MeSH: D018296; MedGen: C0206711; Orphanet: 91414; OMIM: 132600; Human Phenotype Ontology: HP:0030434

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000505400Database of Curated Mutations (DoCM)
no assertion criteria provided
Likely pathogenic
(Jul 14, 2015)
somaticliterature only

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedsomaticyesnot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Prospective enterprise-level molecular genotyping of a cohort of cancer patients.

MacConaill LE, Garcia E, Shivdasani P, Ducar M, Adusumilli R, Breneiser M, Byrne M, Chung L, Conneely J, Crosby L, Garraway LA, Gong X, Hahn WC, Hatton C, Kantoff PW, Kluk M, Kuo F, Jia Y, Joshi R, Longtine J, Manning A, Palescandolo E, et al.

J Mol Diagn. 2014 Nov;16(6):660-72. doi: 10.1016/j.jmoldx.2014.06.004. Epub 2014 Aug 23.

PubMed [citation]
PMID:
25157968
PMCID:
PMC4210463

Details of each submission

From Database of Curated Mutations (DoCM), SCV000505400.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1somaticyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 7, 2023